Patients With Renal Impairment Undergoing CT

Status Completed

Clinical Trial Summary

The purpose of the study is to compare the incidence of contrast induced nephrotoxicity following the administration of Isovue or Visipaque in patients with mild to moderate renal impairment who undergo a clinically indicated IV contrast-enhanced (multidetector computed tomography) MDCT of the liver or MDCT angiography of the lower extremities. Serum Creatinine (SCr) will be measured before and up to 48-72 hours post dose.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Contrast Induced Nephropathy

Clinical Trial Details

NCT number	NCT00292487
Study type	Interventional
Source	Bracco Diagnostics, Inc
Contact
Status	Completed
Phase	Phase 4
Start date	November 2004
Completion date	February 2006

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00842868` - The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases	N/A
Completed	`NCT00634491` - Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast Nephropathy	Phase 2
Terminated	`NCT00476619` - Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial	Phase 4
Recruiting	`NCT03121053` - Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement	Phase 4
Completed	`NCT02650336` - Aging Biomakers and ConTrast Induced Nephropathy (ACTIN) Trial	N/A
Completed	`NCT01741896` - Can Remote Ischaemic Preconditioning Reduce Contrast Induced Nephropathy in Patients Receiving Contrast for Computed Tomography?	N/A
Terminated	`NCT00575419` - Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure	Phase 1
Not yet recruiting	`NCT00392405` - Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate	Phase 2
Recruiting	`NCT04982419` - Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial	Phase 2/Phase 3
Completed	`NCT00770614` - Hydration and Contrast-Induced Nephropathy in Primary Angioplasty	Phase 4
Completed	`NCT01999517` - Contrast Nephropathy and Nitrates	Phase 4
Recruiting	`NCT00702728` - Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy (CIN) Prevention	Phase 3
Completed	`NCT00639912` - Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction.	Phase 4
Completed	`NCT00531765` - Sodium Bicarbonate in Preventing Contrast Induced Nephropathy	N/A
Terminated	`NCT00494637` - The Use of Sodium Bicarbonate in the Prevention of Contrast Induced Nephropathy	N/A
Completed	`NCT02516072` - Use of Remote Ischaemic Preconditioning in the Prevention of Contrast Induced Nephropathy	N/A
Active, not recruiting	`NCT01402232` - REduction of rIsk for Contrast Induced Nephropathy
Recruiting	`NCT02113540` - Assessment of the Effect of Atorvastatin on Prevention of CIN in Patients Undergoing Coronary Angiography	Phase 3
Active, not recruiting	`NCT01456013` - Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients	Phase 3
Recruiting	`NCT01399203` - Contrast Medium Volume and Contrast-induced Nephropathy After Percutaneous Coronary Intervention	N/A